Marijn E. Dekkers, Director at Cerevel Therapeutics Holdings, Inc. (CERE), sold 200,000 shares at $34.43 ($6.9M) on 2023-06-15, disclosed to the SEC on 2023-06-20.
Open-market sale of $6.9M CERE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DNA | SELL | 2022-11-07 | $878K | — | Filing → |
| QTRX | SELL | 2021-06-08 | $1.9M | — | Filing → |
| QTRX | SELL | 2021-01-13 | $3.8M | — | Filing → |